ScoreComparison
Why is Beam Therapeutics, Inc. ?
1
With a growth in Net Sales of 324.87%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- NET SALES(Q) At USD 31.74 MM has Grown at 324.87%
- NET PROFIT(HY) Higher at USD 150.99 MM
- ROCE(HY) Highest at -5.69%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 98.68%, its profits have risen by 76.9%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 98.68% in the last 1 year, much higher than market (S&P 500) returns of 22.24%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Beam Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Beam Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beam Therapeutics, Inc.
98.68%
0.48
75.74%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
168.95%
EBIT Growth (5y)
-197.70%
EBIT to Interest (avg)
-309.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.07
Sales to Capital Employed (avg)
0.21
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.83
EV to EBIT
-2.68
EV to EBITDA
-2.85
EV to Capital Employed
137.03
EV to Sales
7.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5107.73%
ROE (Latest)
-6.85%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
NET SALES(Q)
At USD 31.74 MM has Grown at 324.87%
NET PROFIT(HY)
Higher at USD 150.99 MM
ROCE(HY)
Highest at -5.69%
RAW MATERIAL COST(Y)
Fallen by -225.36% (YoY
CASH AND EQV(HY)
Highest at USD 2,456.86 MM
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -369.73 MM
DEBT-EQUITY RATIO
(HY)
Highest at -82.51 %
Here's what is working for Beam Therapeutics, Inc.
Net Sales
At USD 31.74 MM has Grown at 324.87%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Net Profit
At USD 150.99 MM has Grown at 176.06%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Profit
Higher at USD 150.99 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Cash and Eqv
Highest at USD 2,456.86 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -225.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Beam Therapeutics, Inc.
Operating Cash Flow
Lowest at USD -369.73 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Highest at -82.51 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
